[ad_1]
The British pharmaceutical company Indivior Inc. has been charged with an alleged plan to postpone the treatment of opioid addicts and raise billions of dollars.
A grand jury of the Federal Court in Abingdon, Va., Said that Indivior had marketed Suboxone Film, an opioid-based drug, as a safe and controllable treatment for opioid and drug dependence. l & # 39; heroin.
Tuesday's indictment said that Indivior – until 2014, known as the Reckitt Benckiser group – was seeking to boost sales by illegally informing healthcare providers and programs that Suboxone Film, which contains buprenorphine, was better was not.
The company has also set up a telephone program allowing patients to contact a doctor for a treatment of opioid dependence and addiction, used by Indivior to connect patients to doctors. Indivior knew that they were prescribing Suboxone and / or other opioids in a careless and clinically unjustified manner. the indictment says.
"Indivior's fraudulent scheme lasted for years and hindered accurate badessments of patients, health care providers, and health-care delivery programs regarding the treatment of opioid addiction to increase the benefits of society, "says the grand jury.
The company has been charged with 28 counts of healthcare fraud, mail and wire related to the marketing of Suboxone Film.
In a statement, Indivior, based in Slough (UK) and Richmond (Virginia), described the indictment as "baseless, neither facts nor law".
The Ministry of Justice "apparently decided that he preferred to make headlines on an issue of national importance rather than get an appropriate resolution," he said.
"We will vigorously challenge this case and we look forward to all the facts being revealed in court."
Source link
